MIP-FERMT3
MIP-FERMT3 has been studied in 1 paper since 2026: none in people yet, 1 in cells; 1 in the past year. No study of it in people or animals has been published yet. The newest paper, Jun 25, 2026: “A microprotein encoded by FERMT3 modulates endothelial cell protein catabolism and induces cell cycle arrest and senescence”.
1 paper studies it3 findingsUpdated
See all 1 papers on MIP-FERMT3
At a glance
The findings reach cells, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Deutsche Forschungsgemeinschaft
- Cells1
What did studies of MIP-FERMT3 find?
3Studies of MIP-FERMT3 measured 3 outcomes: CDKN1A, cellular senescence and cell cycle regulation.
CDKN1A
downin human cells1
1 study
CDKN1A
downin human cells1
MIP-FERMT3 decreases CDKN1A in human cells.
“miP-FERMT3 is a novel regulator of protein catabolism that promotes p21 degradation”
Cellsendothelial cell
Cell communication and signaling : CCS
Cellular senescence
upin human cells1
1 study
Cellular senescence
upin human cells1
MIP-FERMT3 induces cellular senescence in human cells.
“These alterations culminated in rapid induction of cellular senescence”
Cellsendothelial cell
Cell communication and signaling : CCS
Cell cycle regulation
upin human cells1
1 study
Cell cycle regulation
upin human cells1
MIP-FERMT3 induces cell cycle regulation in human cells.
“The expression of miP-FERMT3 caused cell cycle arrest and DNA damage, evidenced by γ-H2AX foci and nuclear p53 accumulation.”
Cellsendothelial cell
Cell communication and signaling : CCS